Components of Hepatitis A Vaccine	Excipients Table Allergens Table Components Table
Indication Active immunity against infection caused by hepatitis A Proprietary Names Havrix Vaqta Manufacturers GlaxoSmithKline Merck Viability Inactivated Inactivated Microorganism Single-stranded RNA human enterovirus 72 genus Enterovirus Single-stranded RNA human enterovirus 72 genus Enterovirus Dose     Adult 1 mL 1 mL Pediatric 0.5 mL 0.5 mL Route Intramuscular Intramuscular Dose form Suspension Suspension Appearance Slightly turbid white suspension after shaking Slightly opaque white suspension Concentration     Adult 1440 ELU/mL 50 U/mL Pediatric 720 ELU/0.5mL 25 U/0.5 mL Preservatives none None Adjuvants:     Adult Aluminum hydroxide, 0.5 mg/mL Aluminum hydroxide, 0.45 mg/mL Pediatric Aluminum hydroxide, 0.25/0.5 mL Aluminum hydroxide, 0.225 mg/0.5 mL Excipients Amino acid supplement (0.3% w/v) with 0.05 mg/mL polysorbate-20, Formalin, ≤0.1 mg/mL MRC-5 cellular protein, ≤5 mcg Nonviral protein, <0.1 mcg DNA, <4 x 10-6 mcg Formaldehyde,<0.8 mcg Bovine albumin, <10-4  Allergens Neomycin sulfate, <40 ng/mL Stopper of the vial contains dry natural rubber latex  None Media MRC-5 human diploid cell culture Human MRC-5 diploid fibroblasts Packaging Single dose vials (0.5 [360 and 720 EL.U] and 1 mL)and prefilled syringes Single dose vials (0.5 mL and 1 mL) and prefilled syringes Routine Storage 2 to 8° C (36-46° F) Do not freeze 2 to 8° C (36-46° F) Do not freeze updated May 2010
This page was last updated on November 07, 2012 © 2005 Institute for Vaccine Safety